Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:BMR

Biomed Realty Trust (BMR) Stock Price, News & Analysis

Biomed Realty Trust logo

About Biomed Realty Trust Stock (NYSE:BMR)

Advanced Chart

Key Stats

Today's Range
$2.45
$2.89
50-Day Range
N/A
52-Week Range
$17.94
$25.08
Volume
160,067 shs
Average Volume
3.29 million shs
Market Capitalization
$35.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Receive BMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomed Realty Trust and its competitors with MarketBeat's FREE daily newsletter.

BMR Stock News Headlines

Biomed Realty Tr (BMR)
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
See More Headlines

BMR Stock Analysis - Frequently Asked Questions

Biomed Realty Trust Inc (NYSE:BMR) released its quarterly earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.04. The business's quarterly revenue was up 5.4% on a year-over-year basis.

Biomed Realty Trust (BMR) raised $8 million in an initial public offering on Tuesday, February 28th 2023. The company issued 1,950,000 shares at a price of $4.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biomed Realty Trust investors own include NVIDIA (NVDA), Tesla (TSLA), Ford Motor (F), Meta Platforms (META), Broadcom (AVGO), Norwegian Cruise Line (NCLH) and NIO (NIO).

Company Calendar

Last Earnings
4/28/2015
Today
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
Office REITs
Current Symbol
NYSE:BMR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.91 million
Price / Cash Flow
N/A
Book Value
$0.80 per share
Price / Book
3.48

Miscellaneous

Free Float
N/A
Market Cap
$35.88 million
Optionable
Not Optionable
Beta
5.22
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NYSE:BMR) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners